These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36997001)

  • 41. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.
    Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M
    Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas.
    Al-Kawaaz M; Sanchez T; Kluk MJ
    J Hematop; 2019 Jun; 12(2):57-65. PubMed ID: 31404445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas.
    Behdad A; Bailey NG
    Surg Pathol Clin; 2016 Mar; 9(1):41-54. PubMed ID: 26940267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
    Boerma EG; Siebert R; Kluin PM; Baudis M
    Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
    McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
    Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinicopathologic characteristics of Burkitt-like lymphoma with chromosome 11q aberration].
    Wei P; Zhang YL; Xie JL; Zheng YY; Liu W; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):176-179. PubMed ID: 29534356
    [No Abstract]   [Full Text] [Related]  

  • 47. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
    Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Stejskalová E; Kabícková E
    Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MYC and aggressive B-cell lymphomas.
    Slack GW; Gascoyne RD
    Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.
    Lynnhtun K; Renthawa J; Varikatt W
    Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
    Gebauer N; Bernard V; Feller AC; Merz H
    Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Histoseminar: "The contribution of new molecular biology techniques in the diagnosis of lymphoma: Myth or reality?". Case 1: High grade B-cell lymphoma with 11q aberration].
    Donzel M; Fontaine J; Traverse-Glehen A
    Ann Pathol; 2023 Mar; 43(2):121-125. PubMed ID: 36822907
    [No Abstract]   [Full Text] [Related]  

  • 56. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.
    Kanungo A; Medeiros LJ; Abruzzo LV; Lin P
    Mod Pathol; 2006 Jan; 19(1):25-33. PubMed ID: 16258503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.
    Tanaka Y; Momose S; Tabayashi T; Sawada K; Yamashita T; Higashi M; Sagawa M; Tokuhira M; Rosenwald A; Kizaki M; Tamaru JI
    Cancer Sci; 2020 Feb; 111(2):749-759. PubMed ID: 31849147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggressive B-cell lymphomas: how many categories do we need?
    Said JW
    Mod Pathol; 2013 Jan; 26 Suppl 1(0 1):S42-56. PubMed ID: 23154748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.